Arkolith/Insider Trading/NBRV/Form 4

Gelone Steven P.

President and COO, DirectorNabriva Therapeutics plc (NBRV) · full profile →Form 4 · filed Feb 1, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 28, 2022Grant(A)47K—$047K
Jan 28, 2022Grant(A)93K—$093K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-010483) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML